Form 4: Eli Lilly Executive Ilya Yuffa Sells Shares Under 10b5-1 Trading Plan

Ilya Yuffa, EVP & President, LLY International, sold 1,250 shares of Eli Lilly & Co. common stock at $749.24 per share on May 14, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• On May 14, 2025, Ilya Yuffa, an Executive Vice President at Eli Lilly & Co., sold 1,250 shares of common stock.
• The sale was executed at a price of $749.24 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on February 12, 2025.
• Following the transaction, Ilya Yuffa directly owns 27,509.971 shares of Eli Lilly & Co. common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sale is pre-planned under a 10b5-1 plan, so it doesn't necessarily reflect a change in sentiment.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies and are often conducted under pre-arranged trading plans like Rule 10b5-1 to avoid accusations of insider trading. The sale itself doesn't necessarily indicate a negative outlook on the company.

Stakeholder Impact

• The stock sale by an executive could have a minor psychological impact on shareholders, but the pre-planned nature of the sale mitigates concerns about insider information.

Key Dates

Keywords

Form 4, Ilya Yuffa, Eli Lilly, LLY, Stock Sale, 10b5-1 Trading Plan, Executive, Beneficial Ownership